Collegium Pharmaceutical, Inc. COLL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s operating income?
- Collegium Pharmaceutical, Inc. (COLL) reported operating income of $30.9M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s operating income changed year-over-year?
- Collegium Pharmaceutical, Inc.'s operating income increased by 42.5% year-over-year, from $21.69M to $30.9M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating income?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s operating income has grown at a 78.7% compound annual growth rate (CAGR), from $17.63M to $179.64M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.